查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1636054

按類型（戈謝氏症1 型、戈謝氏症2 型、戈謝氏症3 型等）、診斷和治療（診斷、治療）、最終用戶（醫院、專科診所、家庭護理等）和地區分類的戈謝病市場2025-2033

Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 127 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球戈謝氏症市場IMARC Group達18億美元。越來越多的戈謝氏症患者、廣泛的研發（R＆D）活動以及藥物的容易取得是推動市場發展的一些關鍵因素。

戈謝氏症，也稱為溶小體儲存障礙，是一種罕見的遺傳代謝紊亂，影響身體分解和儲存脂肪的能力。它是由葡萄糖腦苷脂酶缺乏引起的，該酶會分解體內的葡萄糖腦苷脂脂肪化學物質。它與脾臟和肝臟腫大、貧血、容易瘀傷和出血、肺部問題、疲勞、癲癇發作和骨骼異常有關。它是透過各種身體檢查、病史和實驗室測試（例如血液和影像學測試）以及基因測試來確診，以確認基因中是否存在突變。戈謝氏症可以透過藥物、注射、酵素替代療法 (ERT)、骨髓移植和底物減少療法 (SRT) 來治療，有助於最大限度地減少與症狀相關的疼痛並提高生活品質。

戈謝氏症市場趨勢：

目前，個體遺傳異常盛行率的增加和戈謝氏症患者數量的增加是推動全球市場成長的主要因素之一。此外，日益成長的老化人口更容易患上這些疾病，導致對戈謝氏症治療的需求增加。此外，為戈謝氏症治療提供經濟資助、減少醫療費用的健康保險政策的實施也有所增加。除此之外，人們對戈謝氏症、其症狀、診斷以及治療方案的便利性的認知不斷增強，正在對市場產生積極影響。此外，許多國家的政府正在投資研發 (R&D) 活動，以研究戈謝氏症並開發新的治療方法。他們也採取措施向所有人提供優質的醫療設施。再加上診斷技術的顯著改進，正在為市場創造積極的前景。除此之外，人們越來越認知到 ERT 治療替代方案（例如有助於分解葡萄糖腦苷脂並減少累積的口服療法）的便利性，也促進了市場的成長。它們通常涉及非處方藥（OTC）和處方藥，用於緩解與戈謝氏症相關的疼痛。

本報告回答的關鍵問題

  • 全球戈謝病市場有多大？ 2025-2033年全球戈謝氏症市場的預期成長率是多少？
  • 推動全球戈謝氏症市場的關鍵因素是什麼？
  • COVID-19 對全球戈謝氏症市場有何影響？
  • 根據類型，全球戈謝氏症市場的詳細情形如何？
  • 全球戈謝氏症市場的關鍵地區有哪些？
  • 全球戈謝氏症市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球戈謝氏症市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 1 型戈謝病
    • 市場趨勢
    • 市場預測
  • 2 型戈謝病
    • 市場趨勢
    • 市場預測
  • 戈謝氏症 3 型
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：透過診斷與治療

  • 診斷
    • 市場趨勢
    • 關鍵環節
      • 體檢
      • 血液檢查
      • 影像學檢查
      • 懷孕前篩檢和產前檢測
      • 其他
    • 市場預測
  • 治療
    • 市場趨勢
    • 關鍵環節
      • 手術
      • 藥物
      • 其他
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 專科診所
    • 市場趨勢
    • 市場預測
  • 居家護理
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ISU Abxis Co. Ltd.
    • Johnson & Johnson
    • Pfizer Inc.
    • Protalix Biotherapeutics
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112025A6807

The global Gaucher disease market size reached USD 1.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033. Increasing number of patients suffering from Gaucher disease, extensive research and development (R&D) activities, and the easy availability of drugs represent some of the key factors driving the market.

Gaucher disease, also known as lysosomal storage disorder, is a rare genetic metabolic disorder that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in the body. It is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, and bone abnormalities. It is diagnosed through various physical examinations, medical history, and laboratory tests, such as blood and imaging tests, and genetic testing to confirm the presence of a mutation in the gene. Gaucher disease can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, and substrate reduction therapy (SRT), which aid in minimizing the pain associated with the symptoms and improve the quality of life.

Gaucher Disease Market Trends:

At present, the increasing prevalence of genetic abnormalities among individuals and the rising number of patients suffering from Gaucher disease represent one of the major factors bolstering the market growth around the world. Moreover, the growing aging population that is more prone to developing these medical disorders is resulting in an increasing demand for Gaucher disease treatment. In addition, there is a rise in the implementation of health insurance policies that provide financial assistance for Gaucher disease treatment and reduce medical expenses. Apart from this, the growing awareness about Gaucher disease, its symptoms, diagnosis, and the easy availability of the treatment options is influencing the market positively. Furthermore, governments of numerous countries are investing in research and development (R&D) activities to study Gaucher disease and develop new treatments. They are also undertaking measures to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is creating a positive outlook for the market. Besides this, the rising awareness about the easy availability of ERT treatment alternatives like oral therapies that help break down glucocerebroside and reduce the accumulation is contributing to the growth of the market. They generally involve generic drugs that are readily available over the counter (OTC) and by prescription for relieving pain associated with Gaucher disease.

Key Market Segmentation:

Type Insights:

  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Others

Diagnosis and Treatment Insights:

  • Diagnosis
  • Physical Exam
  • Blood Tests
  • Imaging Tests
  • Preconception Screening and Prenatal Testing
  • Others
  • Treatment
  • Surgery
  • Medication
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Gaucher disease. Some of the factors driving the North America Gaucher disease market included increasing prevalence of genetic abnormalities, the presence of a well-established healthcare infrastructure, the integration of advanced medical technologies, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global Gaucher disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ISU Abxis Co. Ltd., Johnson & Johnson, Pfizer Inc., Protalix Biotherapeutics, Sanofi S.A, Takeda Pharmaceutical Company Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global Gaucher disease market?
  • 2. What is the expected growth rate of the global Gaucher disease market during 2025-2033?
  • 3. What are the key factors driving the global Gaucher disease market?
  • 4. What has been the impact of COVID-19 on the global Gaucher disease market?
  • 5. What is the breakup of the global Gaucher disease market based on the type?
  • 6. What are the key regions in the global Gaucher disease market?
  • 7. Who are the key players/companies in the global Gaucher disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gaucher Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gaucher Disease Type 1
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gaucher Disease Type 2
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gaucher Disease Type 3
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis and Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Physical Exam
      • 7.1.2.2 Blood Tests
      • 7.1.2.3 Imaging Tests
      • 7.1.2.4 Preconception Screening and Prenatal Testing
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Surgery
      • 7.2.2.2 Medication
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Homecare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ISU Abxis Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Pfizer Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Protalix Biotherapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Sanofi S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Takeda Pharmaceutical Company Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Gaucher Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Gaucher Disease Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Gaucher Disease Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Gaucher Disease Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Gaucher Disease Market: Breakup by Diagnosis and Treatment (in %), 2024
  • Figure 6: Global: Gaucher Disease Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Gaucher Disease Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Gaucher Disease (Gaucher Disease Type 1) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Gaucher Disease (Gaucher Disease Type 1) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Gaucher Disease (Gaucher Disease Type 2) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Gaucher Disease (Gaucher Disease Type 2) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Gaucher Disease (Gaucher Disease Type 3) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Gaucher Disease (Gaucher Disease Type 3) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Gaucher Disease (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Gaucher Disease (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Gaucher Disease (Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Gaucher Disease (Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Gaucher Disease (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Gaucher Disease (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Gaucher Disease (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Gaucher Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Gaucher Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Gaucher Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Gaucher Disease (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Gaucher Disease (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Gaucher Disease (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Gaucher Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Gaucher Disease Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Gaucher Disease Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Gaucher Disease Industry: Value Chain Analysis
  • Figure 79: Global: Gaucher Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gaucher Disease Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Gaucher Disease Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Gaucher Disease Market Forecast: Breakup by Diagnosis and Treatment (in Million USD), 2025-2033
  • Table 4: Global: Gaucher Disease Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Gaucher Disease Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Gaucher Disease Market: Competitive Structure
  • Table 7: Global: Gaucher Disease Market: Key Players